Abstract
"How publicly funded research will be brought to market for the next quarter-decade was the topic of a House of Representatives hearing on Tuesday (July 17th), with panelists representing research institutions, universities and high-tech industries. None of them disputed the impact of the law, and in fact no one giving testimony seemed to like the idea of changing the legislation (or passing more of it). But they didn’t say it was perfect. "